Dr. Perugino provides a patient-centric overview of the science of IgG4-RD, and Dr. Stone shares information on the current two phase 3 IgG4-RD clinical trials: the MITIGATE Trial and the INDIGO Trial. In addition to those presentations, Dr. Stone answered some pre-submitted patient questions during a Q and A.
26 фев 2024
